Non-Public Variant Reporting Hampers Consistency of Sequence Interpretation Between Labs
...
Already a member? Log in here
Ambry Genetics Launches Public Genetic Database, Takes Stand on Data Sharing
From - Diagnostic Testing & Emerging Technologies
Ambry Genetics (Aliso Viejo, Calif.) took a stance in the debate over sharing of genetic data this week. The genetic testing firm launched…
Already a member? Log in here
New IOM Report on Biomarker Tests Calls for Improved Evidence, Oversight
From - National Intelligence Report
Few dispute the promise of personalized—or, more recently, "precision"—medicine, but in a world where…
Already a member? Log in here
As Precision Medicine Initiative Evolves, Labs Play Just a Small Role—for Now
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
Already a member? Log in here